Arçelik (ARCLK) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
6 Jan, 2026Executive summary
Q2 2025 revenues reached TRY 121.4 billion, down 11.5% year-on-year in real terms, mainly due to weak international demand and unfavorable product mix, especially in Europe.
Net sales for H1 2025 were TRY 237.0 billion, down from TRY 243.0 billion year-over-year, with a net loss of TRY 5.0 billion compared to a net profit of TRY 22.6 billion in the prior year.
Gross margin improved to 28.4% in Q2, supported by lower raw material costs, favorable euro/dollar parity, and production footprint optimization.
Adjusted EBITDA margin rose to 5.9% in Q2, with further improvement to 7% when excluding inflation accounting impacts.
Net loss before minority was TRY 3 billion in Q2, with a negative net margin of 2.4%.
Financial highlights
Consolidated revenue was TRY 121.4 billion in Q2, an 11.5% real decline year-on-year but a 5% sequential increase.
Gross profit for H1 2025 was TRY 67.6 billion, slightly down from TRY 69.4 billion year-over-year.
Operating profit increased 56% to TRY 1,707mn in Q2, but dropped to TRY 5.3 billion for H1 from TRY 24.1 billion year-over-year.
Adjusted EBITDA of TRY 7.1 billion in Q2, with one-off transaction expenses of TRY 70 million excluded.
Free cash flow was negative at -TRY 23.8 billion in H1, mainly due to increased trade receivables and restructuring outflows.
Outlook and guidance
2025 guidance maintained: flat domestic sales in real terms, 15% international revenue growth in euro terms, 6.5% EBITDA margin, and net working capital/sales ratio around 20%.
EUR 300 million CapEx planned for 2025; further improvement in leverage and working capital expected by year-end.
Positive impacts from new product launches and brand strategy in Europe expected to be visible from Q3, especially in September–November.
The company expects to recover deferred tax assets related to investment incentives within 10 years, with sensitivity analysis showing no change in projected recovery periods under macroeconomic fluctuations.
Ongoing sale of assets held for sale in Poland is expected to complete within twelve months as part of production optimization.
Latest events from Arçelik
- Revenue fell and a net loss was posted, but cash flow and profitability improved in tough markets.ARCLK
Q4 202516 Feb 2026 - Revenue surged after acquisitions, but margins and net income fell amid higher costs.ARCLK
Q2 20242 Feb 2026 - Revenue up 14% YoY, but margins and net income declined amid integration and cost pressures.ARCLK
Q3 202418 Jan 2026 - Revenue up 15% but margins and net income fell; 2025 targets margin and efficiency gains.ARCLK
Q4 20249 Jan 2026 - Q3 revenue dropped 11.4% y/y, but margins improved amid restructuring and acquisitions.ARCLK
Q3 202514 Dec 2025 - Sales up 9.3% y/y, but net loss and margin pressure amid restructuring and inflation.ARCLK
Q1 202529 Nov 2025